《沪深两市》上证深成半日升0.4%至1% 国寿扬逾3% 制药股造高
今早(20日)人民币兑美元中间价上调214点，报6.8664兑一美元，创去年7月19日後约半年高位。国务院总理李克强称，新的一年，继续开展大规模制度性减税，保持经济运行在合理区间。此外，人行在春节前向市场提供流动性，上周三至今净投放量达1.35万亿元人民币(下同)。上证、深成今早高开约0.2%後，早市升幅扩大。
沪综指半日升13点或0.4%，以最高位收报3,088；深成指半日升107点或1%，以最高位收报11,061；沪深300指数半日升21点或0.5%，报4,176；创业版指数半日急升38点或2%，报1,970。沪深两市半日成交分别约1,651亿及2,467亿元。
主要金融股小幅上行，农行(601288.SH)、工行(601398.SH)及兴业银行(601166.SH)半日升0.3%至0.7%、建行(601939.SH)微升0.1%。平安(601318.SH)则升2%。
国寿(601628.SH)半日升3.3%，公司今早发盈喜，经公司初步测算，预计2019年度归属於公司股东的净利润较2018年度增加约455.80亿元到478.59亿元，同比增幅约400%到420%。招行(600036.SH)半日升0.8%，该行上周五(17日)公布业绩快报，净利润料为928.67亿元，按年上升15.28%。
武汉市卫健委通报新型冠状病毒感染的肺炎最新情况，1月18日0时至1月19日22时，新增136宗新型冠状病毒肺炎病例，治愈出院6宗，死亡1宗。生物制药板块造高，四环生物(000518.SZ)、海王生物(000078.SZ)、香雪制药(300147.SZ)、鲁抗医药(600789.SH)、莱茵生物(002166.SZ)、以岭药业(002603.SZ)、科华生物(002022.SZ)及联环药业(600513.SH)涨停。
猪肉股正邦科技(002157.SZ)半日升3.5%，预计2019年盈利16亿至18亿元，同比大幅增长727.2%至830.6%。
飞机制造、电子零件、金融及房地产等板块半日跑赢大市；酒店旅游、酿酒及传媒娱乐等板块则跑输大市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
